Home›Companies›Biotech & Pharma›GNT Pharmaceuticals

GNT Pharmaceuticals, Inc.

Updated Oct 27, 2026·Latest SEC filing Mar 3, 2025·Suggest an edit

About GNT Pharmaceuticals

GNT Pharmaceuticals is a private company based in Louisville, Kentucky, incorporated in 2024 in Delaware. It has reported $0 raised in one offering on Form D since March 2025. Its chief executive is Phoebe Wood.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Not yetMar 3, 2025$0of $150K target0—EquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on GNT Pharmaceuticals's Form D filed Mar 3, 2025.

PW
Phoebe Wood
Chief Executive Officer and director
SM
DB
Dale Boden
Director
LH
Larry Horn
Executive officer and director
JC
Jim Corman
Director

Sources

  1. SECGNT Pharmaceuticals, Inc. filing history